About Us
Ravon Sazeh Company was established in Tehran in 1370 with the aim of operating in various sectors of construction, construction, road construction, oil, gas, energy and petrochemical industries. Active and effective presence in the implementation of various projects in Abadan Refinery, Arak Petrochemical, Bandar Imam Khomeini Petrochemical, Kohrang Power Plant, Parand Power Plant, Levark Power Plant, Gatond Dam and Power Plant, Dalahu Power Plant, etc. shows the scientific and practical capabilities of Ravon Sazeh Company. It has been growing in the successful implementation of large projects for more than a quarter of a century .
Signing a direct and exclusive contract for the provision of "skilled and expert" manpower for reputable European companies such as Total Fina and Royal Dutch Shell in South Pars, Khark Island and Arak Petrochemical projects, as well as signing a contract with the Fuel Consumption Optimization Organization in order to build And managing the operation of fuel stations in Tehran and Mashhad brought other parts of the company's abilities, capacities and capabilities to the fore.
During its years of activity, Ravan Sazeh Company as the official representative of Fillipo Fochi in Italy, Apave in France, HRP Systems in America, Nencini in Italy, C.M.R in France, etc., played a role in the growing development of the country's industries in the oil and gas, petrochemical and marine sectors. It has been very influential .
According to the successful experiences gained in the previous years and with the intellectual, scientific and executive support of the company's founders and managers, in the early eighties, entering the field of designing and managing projects for the construction of hospital and treatment centers was keyed, which until now and in a trend It continues to excel. Among the most important projects implemented so far, we can mention Irfan Tehran Specialized and Subspecialty Hospital, Mehr Rasht Medical Center, Negh Tehran Ophthalmology Clinic, Mehr Rasht Research Center, Irfan Doctors Building in Tehran and recently the modern and advanced specialized and subspecialty hospital. Niayesh Tehran and Navid infertility treatment clinic in Tehran mentioned.
Also, during nearly 30 years of continuous and extensive activity, the company has successfully designed and implemented all kinds of commercial, industrial, administrative and residential projects in different cities of the country.
Following the imposition of international sanctions against Iran and the withdrawal of large companies from the country, as well as the impossibility of continuing cooperation with the companies that we were active as their official representatives in Iran; After years of successful activity in the above fields and with the support of capabilities and capabilities as well as scientific and practical records and experiences of the founders and senior managers of the company, since 2008 and with the beginning of the construction and equipping of the center in a space of more than 1000 square meters In Pardis Science and Technology Park, we entered the field of research, production and sale of all kinds of medical and laboratory equipment and supplies.
After the completion of the construction and equipping of the building in 1993, in order to increase productivity and speed things up, in the first step, we focused on research activities and the application of advanced technologies in the fields of infertility and embryology. And research has been carried out in order to compensate the country's need for imports; The design and production of the CO2 incubator was approved as the first strategic product of the company and was placed on the agenda.
Finally, in 1995 and after the continuous efforts of our colleagues, we succeeded in the final production of the first samples of CO2 incubators in Iran, which fortunately were approved by them after being used in various research, medical and academic centers in the country. This company won the title of Basic Knowledge in 2016.
Today, this company has managed to include more than 50 products in its product portfolio, most of them after passing various stages of testing and quality control, as well as undergoing clinical tests in various reputable government and private medical centers. The commercialization has reached and the few remaining cases will be able to be offered to the market in the near future.
